liu.seSearch for publications in DiVA
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Hyperestrogenism Affects Adult Height Outcome in Growth Hormone Treated Boys With Silver-Russell Syndrome
Ryhov Cty Hosp, Sweden; Univ Gothenburg, Sweden.
Univ Gothenburg, Sweden.
Linköping University, Department of Clinical and Experimental Medicine, Division of Children's and Women's health. Linköping University, Faculty of Medicine and Health Sciences. Ryhov Cty Hosp, Sweden.
Univ Gothenburg, Sweden.
Show others and affiliations
2018 (English)In: Frontiers in Endocrinology, ISSN 1664-2392, E-ISSN 1664-2392, Vol. 9, article id 780Article in journal (Refereed) Published
Abstract [en]

Background: Intrauterine growth retardation and short stature are common features in Silver-Russell syndrome (SRS). Despite recombinant growth hormone (rGH) treatment, poor pubertal height gain, affecting adult height (AH), is common. This study investigated whether growth patterns and estrogen concentrations are associated with AH outcome in rGH treated SRS males. Methods: In this retrospective longitudinal single-center study, 11 males with SRS were classified as non-responders (NR = 6) or responders (R = 5), depending on AH adjusted for midparental height. Epigenetic analysis and longitudinal growth measures, including bone age, rGH related parameters, pubertal development, gonadotropins and estrogen concentrations, were analyzed until AH. Results: Pubarche before 9 years was only observed in one NR. At 10 years of age, there was no difference in gonadotropins between NR and R. However, estradiol (E2) concentrations at 10 years of age showed a strong association to AH adjusted for MPH (r = -0.78, p amp;lt; 0.001). Serum E2 (pmol/L) was significantly higher in NR at ages 10 years [median (range) 2 (amp;lt;2-5) vs. amp;lt;2 (amp;lt;2)], 12 years [23 (10-57) vs. 2 (amp;lt;2-2)] and 14 years [77 (54-87) vs. 24 (amp;lt;2-38)] but not at 16 years. Birth weight standard deviation score (SDS) was lower in NR [-4.1 (-4.7 to -2.1) vs. -2.7 (-3.3 to -1.7)]. Weight gain (SDS) until pubertal onset was greater in NR [2.4 (1.4-3.5) vs. 0.8 (-0.4 to 1.7)] and pubertal height gain (SDS) was lower in NR [-1.0 (-2.7-0.4) vs. 0.1 (-0.1 to 1.1)]. At AH, a number of NR and R had high E2 concentrations and small testes. Conclusion: Increased E2 concentrations at age 10, 12, and 14 years were associated to less pubertal height gain, thus affecting AH. Due to the small number of patients, the results need to be confirmed in larger cohorts. The finding of impaired testicular development stresses the need of hormonal evaluation as a complement to clinical and radiological assessment when predicting AH in males with SRS.

Place, publisher, year, edition, pages
FRONTIERS MEDIA SA , 2018. Vol. 9, article id 780
Keywords [en]
small for gestational age; estrogens; puberty; mass spectrometry; hypogonadism; gonadotropins; Silver-Russell syndrome; adult height
National Category
Endocrinology and Diabetes
Identifiers
URN: urn:nbn:se:liu:diva-153663DOI: 10.3389/fendo.2018.00780ISI: 000454065300001OAI: oai:DiVA.org:liu-153663DiVA, id: diva2:1276249
Note

Funding Agencies|Futurum - the Academy for Health and Care, Region Jonkoping County [FUTURUM-575601, FUTURUM-765281, FUTURUM-578061, FUTURUM-709351]; Pfizer [WI 182827]; IngaBritt and Arne Lundberg Research Foundation [2015-103]; Swedish government [ALFGBG-507931]; county councils, the ALF [ALFGBG-507931]

Available from: 2019-01-07 Created: 2019-01-07 Last updated: 2019-03-15

Open Access in DiVA

fulltext(1092 kB)46 downloads
File information
File name FULLTEXT01.pdfFile size 1092 kBChecksum SHA-512
7c7da94044c94b6cd2cc1f247cfb0fee81949304b9882c21950caab0fe81b2828e1f80ab63075121947dbe8870c72b7021e170977303c67dcf47e32810a4100e
Type fulltextMimetype application/pdf

Other links

Publisher's full text

Search in DiVA

By author/editor
Åkesson, Karin
By organisation
Division of Children's and Women's healthFaculty of Medicine and Health Sciences
In the same journal
Frontiers in Endocrinology
Endocrinology and Diabetes

Search outside of DiVA

GoogleGoogle Scholar
Total: 46 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

doi
urn-nbn

Altmetric score

doi
urn-nbn
Total: 63 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf